Can a heart scan predict chemo danger?
NCT ID NCT06511388
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to find early markers of heart damage from chemotherapy in people with sarcoma. Researchers used advanced heart imaging (2D and 3D echocardiography) to track changes in heart function over time. The goal was to identify patients at highest risk for heart failure before it happens. The study was terminated early, so results are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can engineered immune cells tackle childhood sarcoma?
- Can a Patient's own immune cells be engineered to fight a rare sarcoma?
- Can a Patient's own immune cells fight advanced sarcoma?
- Could a massive tissue bank unlock sarcoma's secrets?
- Can a new protein drug shield kids with cancer from dangerous infections?
- Can two drugs together fight Hard-to-Treat bone and Soft-Tissue cancers?